Literature DB >> 4418931

[Fiedler's acute myocarditis].

J A Fournier Andray, F Errazquin Saenz de Tejada, J González del Castillo.   

Abstract

Entities:  

Mesh：

Year:  1974        PMID： 4418931

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN： 0300-8932            Impact factor:   4.753


× No keyword cloud information.
  5 in total

Review 1.  Prostate cancer.

Authors:  Richard J Rebello; Christoph Oing; Karen E Knudsen; Stacy Loeb; David C Johnson; Robert E Reiter; Silke Gillessen; Theodorus Van der Kwast; Robert G Bristow
Journal:  Nat Rev Dis Primers       Date:  2021-02-04       Impact factor: 52.329

2.  Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study.

Authors:  Kristine Kreis; Dirk Horenkamp-Sonntag; Udo Schneider; Jan Zeidler; Gerd Glaeske; Lothar Weissbach
Journal:  Pharmacoecon Open       Date:  2021-06

3.  Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan.

Authors:  Akira Yokomizo; Junji Yonese; Shin Egawa; Hiroshi Fukuhara; Hiroji Uemura; Kazuo Nishimura; Masayoshi Nagata; Atsushi Saito; Takumi Lee; Susumu Yamaguchi; Norio Nonomura
Journal:  Int J Clin Oncol       Date:  2021-11-15       Impact factor: 3.402

4.  Stereotactic radiotherapy to oligoprogressive lesions detected with 68Ga-PSMA-PET/CT in castration-resistant prostate cancer patients.

Authors:  Cem Onal; Gokhan Ozyigit; Ezgi Oymak; Ozan Cem Guler; Burak Tilki; Pervin Hurmuz; Fadil Akyol
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-10       Impact factor: 9.236

5.  Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors.

Authors:  Neal D Shore; François Laliberté; Raluca Ionescu-Ittu; Lingfeng Yang; Malena Mahendran; Dominique Lejeune; Louise H Yu; Joseph Burgents; Mei Sheng Duh; Sameer R Ghate
Journal:  Adv Ther       Date:  2021-07-19       Impact factor: 3.845
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.